| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/02/1993 | WO1993002661A1 Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
| 02/02/1993 | USH1139 Combination of a calcium channel blocker and thromboxane A2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination |
| 02/02/1993 | US5183925 Leukotriene-b4 derivatives, process for their production and their use as pharmaceutical agents |
| 02/02/1993 | US5183906 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2 (5h)-furanones as anti-inflammatory agents |
| 02/02/1993 | US5183903 Heating together 3-phenoxyazetidine derivative and urea in the absence of a solvent |
| 02/02/1993 | US5183902 Muscle relaxants |
| 02/02/1993 | US5183900 Matrix metalloprotease inhibitors |
| 02/02/1993 | US5183896 Used for treatment of memory disorders in old people such as senile dementia and Alzheimer's disease |
| 02/02/1993 | US5183889 Benzonaphtahalene derivatives, a process for their preparation and their use in therapeutic and cosmetic compositions |
| 02/02/1993 | US5183882 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
| 02/02/1993 | US5183829 Oral liquid compositions of non-steroidal anti-inflammatory drugs |
| 02/02/1993 | US5183828 Ribonucleotide reductase inhibitor and free radical scavenger |
| 02/02/1993 | US5183826 Antiviral agent |
| 02/02/1993 | US5183823 Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents |
| 02/02/1993 | US5183822 Substituted 3,4-annelated benzimidazol-2(1h)-ones |
| 02/02/1993 | US5183821 Method for treating leukemias using N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide for treating leukemias and solid tumors |
| 02/02/1993 | US5183819 Use of fused bicyclic imides in the treatment of various CNS disorders |
| 02/02/1993 | US5183817 Combinations of retinoids and minoxidil-type compounds for hair growth |
| 02/02/1993 | US5183814 Selective oestrogen therapy for perimenopausal or postmenopausal conditions |
| 02/02/1993 | US5183813 Antiarrhythmic agents |
| 02/02/1993 | US5183809 Cyclodextrin polymers and cyclodextrins immobilized on a solid surface |
| 02/02/1993 | US5183807 Use of monosialoganglioside gm, to prevent the development of tolerance to the analgesic effect of morphine and related drugs |
| 02/02/1993 | US5183687 Method of treating poultry for coccidiosis |
| 02/02/1993 | US5183674 Food and feedstuff |
| 02/02/1993 | US5183667 Treating tumor disease by administering culture product containing beta-glucan |
| 02/02/1993 | US5183665 Using antihistamine |
| 02/02/1993 | US5183662 Controlled drug release composition |
| 02/02/1993 | US5183061 Administering a compound in which silicon is solely bonded to oxygen or halogen, not less than one-fourth of valences bonding to oxygen |
| 02/02/1993 | CA2114225A1 Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
| 02/02/1993 | CA2075010A1 Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor |
| 02/02/1993 | CA2074861A1 Microorganism for producing c-31 desmethyl fr-900520 cyclic hemiketal immunosuppressant agent |
| 02/02/1993 | CA2074856A1 C-31 desmethyl fr-900520 cyclic hemiketal immunosuppressant agent |
| 02/02/1993 | CA1313378C Crystalline 2-(1-pentyl-3-guanidino)-4-(2-methyl-4- imidazolyl)thiazole dihydrochloride trihydrate |
| 02/02/1993 | CA1313372C Polycyclic heterocyclic derivatives, a process for their preparation and their application to veterinary and human medicine |
| 02/02/1993 | CA1313371C Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation |
| 02/02/1993 | CA1313370C Cyclopolyglycuronic acid composition and treatment |
| 02/02/1993 | CA1313329C Nicarbazin feed premix |
| 02/01/1993 | CA2075102A1 6-oxoazepinoindole compounds, processes and intermediates for their preparation and pharmaceutical compositions containing them |
| 02/01/1993 | CA2075017A1 (isoquinolein-5-yl) sulfonamides, process for their prepara tion and pharmaceutical compositions containing them |
| 02/01/1993 | CA2074963A1 New n-[(isoquinolein-5-yl)sulfonyl] azacycloalcanes, preparation process and pharmaceutical compositions containing them |
| 02/01/1993 | CA2074788A1 Qinolin-2-yl-methoxybenzylhydroxyureas |
| 02/01/1993 | CA2074777A1 N-alkylated 1,4-dihydropyridinedicarboxylic acid esters |
| 02/01/1993 | CA2071160A1 Asymmetric synthesis of taxol side chain |
| 02/01/1993 | CA2071140A1 Production of pradimicin antibiotics by fermentation |
| 01/31/1993 | CA2074864A1 Tetralones with pharmacological activity |
| 01/31/1993 | CA2074846A1 "2-(imidazol-1-yl)-2-benzylethylidene-aminoxyalkanoic acid derivatives" |
| 01/31/1993 | CA2074797A1 Certain heteroaryl substituted hydroxylamine derivatives |
| 01/31/1993 | CA2074709A1 Use of 1,4-dihydropyridines in diabetes |
| 01/31/1993 | CA2055381A1 Oligosaccharide derivatives |
| 01/30/1993 | CA2074542A1 Sulphur containing non-steroidal drugs as 5-alpha reductase inhibitors |
| 01/30/1993 | CA2074537A1 Catechol type non-steroidal drugs as 5-alpha reductase inhibitors |
| 01/28/1993 | WO1993002670A1 Radioprotection by calcium antagonists |
| 01/28/1993 | DE4124695A1 Use of carbocycline derivs. - esp. iloprost, cicaprost, eptaloprost, beraprost or ciprostene, for treatment of psoriasis vulgaris |
| 01/28/1993 | DE4124693A1 Use of carbocycline derivs. - esp. iloprost, cicaprost, eptaloprost, beraprost or ciprostene, for treatment of vitiligo |
| 01/28/1993 | DE4124503A1 Compsn. for inducing puberty and synchronising oestrus in young sows - contains PGF2 alpha or its analogue, esp. cloprostenol providing improved litter size |
| 01/28/1993 | DE4124252A1 Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung Process for the preparation of a sterilized by drug-spoon |
| 01/28/1993 | DE4108395A1 Verwendung von oxazolo-(2,3-a)isoindol-und imidazo(2,1-a)-isoindol-derivaten als antivirale arzneimittel sowie neue oxazolo(2,3-a)isoindol-derivaten Use of oxazolo- (2,3-a) isoindole-and imidazo (2,1-a) -isoindol derivatives as antiviral drug as well as new -oxazolo (2,3-a) isoindole derivatives |
| 01/28/1993 | CA2092408A1 Radioprotection by calcium antagonists |
| 01/28/1993 | CA2075354A1 Beta-substituted cinnamic acid derivative |
| 01/28/1993 | CA2074685A1 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical compositions containing these compounds |
| 01/28/1993 | CA2072529A1 2-piperidinylpyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics |
| 01/28/1993 | CA2072434A1 2-aminopyrimidine-4-carboxamide, their preparation and their use in therapeutics |
| 01/27/1993 | EP0524846A1 2-(Piperidin-1-yl)ethanol derivatives, their preparation and their use in therapeutics |
| 01/27/1993 | EP0524796A1 Use of essential fatty acids in the preparation of a medicament for the treatment of AIDS |
| 01/27/1993 | EP0524784A1 Benzopyrido piperidylidene compounds as PAF antagonists |
| 01/27/1993 | EP0524781A1 Therapeutic amides |
| 01/27/1993 | EP0524742A2 Benzo(a)fluorene compounds |
| 01/27/1993 | EP0524696A1 Oral compositions containing dapiprazole |
| 01/27/1993 | EP0524686A1 A process for the 14a-hydroxylation of avermectin compounds |
| 01/27/1993 | EP0524633A2 Pharmaceutical composition suitable for influencing the reticuloendothelial system |
| 01/27/1993 | EP0524632A1 Pleuromutilin complexes |
| 01/27/1993 | EP0524602A2 Compositions for the treatment of inflammations of the skin |
| 01/27/1993 | EP0524595A1 Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof |
| 01/27/1993 | EP0524587A1 Therapeutic compositions for intranasal administration which include ketorolac TM |
| 01/27/1993 | EP0524582A1 Diclofenac sodium plaster |
| 01/27/1993 | EP0524579A1 Improved oral dosing formulations of dideoxy purine nucleosides |
| 01/27/1993 | EP0524548A1 Antimicrobial mixtures |
| 01/27/1993 | EP0524517A1 Substituted 3,4-dihydronaphthalenes, medicament containing them and process for their preparation |
| 01/27/1993 | EP0524512A2 Antihypertensive combinations |
| 01/27/1993 | EP0524439A1 Novel cyclohexane and tetrahydropyran derivatives and antifungal compositions containing these derivatives |
| 01/27/1993 | EP0524395A1 Sustained release compositions containing bile acids |
| 01/27/1993 | EP0524308A1 Nutritional supplement containing vitamin e |
| 01/27/1993 | EP0524283A1 Pharmaceutical product for treating viral diseases |
| 01/27/1993 | EP0524212A1 Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases |
| 01/27/1993 | EP0524190A1 Hmg-co a reductive inhibitors |
| 01/27/1993 | EP0524180A1 Taste masking of ibuprofen by fluid bed coating. |
| 01/27/1993 | EP0409940A4 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 01/27/1993 | EP0387328B1 Glyceride containing nutrient for human and animals |
| 01/27/1993 | CN1068333A Pharmacologically active hydrazine derivatives and processes for preparation thereof |
| 01/27/1993 | CN1068332A Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories |
| 01/27/1993 | CN1068329A Pyrazolopyrimidinone antianginal agents |
| 01/27/1993 | CN1068328A Pyrrolopyrazine |
| 01/27/1993 | CN1068327A Process for preparing 14-0-acylate of aconite alkaloid type compounds |
| 01/27/1993 | CA2074601A1 Pyrazole derivatives |
| 01/26/1993 | WO1993001803A1 Controlled release verapamil tablet |
| 01/26/1993 | US5182396 1-hydroxyvitamin d derivatives |
| 01/26/1993 | US5182383 Ceftazidime |
| 01/26/1993 | US5182378 Sulfate derivatives of galactan extracted from klebsiella |
| 01/26/1993 | US5182370 Paramagnetic chelates |
| 01/26/1993 | US5182306 Use of colchicine for the control of retroviruses |